Literature DB >> 20385973

Ribonucleic acid interference knockdown of interleukin 6 attenuates cold-induced hypertension.

Patrick Crosswhite1, Zhongjie Sun.   

Abstract

The purpose of this study was to determine the role of the proinflammatory cytokine interleukin (IL) 6 in cold-induced hypertension. Four groups of male Sprague-Dawley rats were used (6 rats per group). After blood pressure was stabilized, 3 groups received intravenous delivery of adenoassociated virus carrying IL-6 small hairpin RNA (shRNA), adenoassociated virus carrying scrambled shRNA, and PBS, respectively, before exposure to a cold environment (5 degrees C). The last group received PBS and was kept at room temperature (25 degrees C, warm) as a control. Adenoassociated virus delivery of IL-6 shRNA significantly attenuated cold-induced elevation of systolic blood pressure and kept it at the control level for < or =7 weeks (length of the study). Chronic exposure to cold upregulated IL-6 expression in aorta, heart, and kidneys and increased macrophage and T-cell infiltration in kidneys, suggesting that cold exposure increases inflammation. IL-6 shRNA delivery abolished the cold-induced upregulation of IL-6, indicating effective silence of IL-6. Interestingly, RNA interference knockdown of IL-6 prevented cold-induced inflammation, as evidenced by a complete inhibition of tumor necrosis factor-alpha expression and leukocyte infiltration by IL-6 shRNA. RNA interference knockdown of IL-6 significantly decreased the cold-induced increase in vascular superoxide production. It is noted that IL-6 shRNA abolished the cold-induced increase in collagen deposition in the heart, suggesting that inflammation is involved in cold-induced cardiac remodeling. Cold exposure caused glomerular collapses, which could be prevented by knockdown of IL-6, suggesting an important role of inflammation in cold-induced renal damage. In conclusion, cold exposure increased IL-6 expression and inflammation, which play critical roles in the pathogenesis of cold-induced hypertension and cardiac and renal damage.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20385973      PMCID: PMC2894564          DOI: 10.1161/HYPERTENSIONAHA.109.146902

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  50 in total

1.  Prolonged reduction of high blood pressure with an in vivo, nonpathogenic, adeno-associated viral vector delivery of AT1-R mRNA antisense.

Authors:  M I Phillips; D Mohuczy-Dominiak; M Coffey; S M Galli; B Kimura; P Wu; T Zelles
Journal:  Hypertension       Date:  1997-01       Impact factor: 10.190

2.  Cold-induced hypertension. A model of mineralocorticoid-induced hypertension.

Authors:  Z Sun; J R Cade; M J Fregly
Journal:  Ann N Y Acad Sci       Date:  1997-03-15       Impact factor: 5.691

3.  Development of hypertension in rats during chronic exposure to cold.

Authors:  M J Fregly; D C Kikta; R M Threatte; J L Torres; C C Barney
Journal:  J Appl Physiol (1985)       Date:  1989-02

4.  Effect of renal denervation on elevation of blood pressure in cold-exposed rats.

Authors:  Z Sun; M J Fregly; J R Cade
Journal:  Can J Physiol Pharmacol       Date:  1995-01       Impact factor: 2.273

5.  Seasonal variations in office, home and 24 h ambulatory blood pressure in patients with essential hypertension.

Authors:  J Minami; Y Kawano; T Ishimitsu; H Yoshimi; S Takishita
Journal:  J Hypertens       Date:  1996-12       Impact factor: 4.844

6.  Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation.

Authors:  Danilo Fliser; Konrad Buchholz; Hermann Haller
Journal:  Circulation       Date:  2004-08-16       Impact factor: 29.690

7.  [Seasonal variations in arterial pressure in hypertensive patients].

Authors:  F Verdon; J F Boudry; M Chuat; J P Studer; C B Truong; E Jacot
Journal:  Schweiz Med Wochenschr       Date:  1993-12-18

8.  Winter weather and cardiovascular mortality in Minneapolis-St. Paul.

Authors:  A Baker-Blocker
Journal:  Am J Public Health       Date:  1982-03       Impact factor: 9.308

9.  Angiotensin II stimulates interleukin-6 release from cultured mouse mesangial cells.

Authors:  T Moriyama; M Fujibayashi; Y Fujiwara; T Kaneko; C Xia; E Imai; T Kamada; A Ando; N Ueda
Journal:  J Am Soc Nephrol       Date:  1995-07       Impact factor: 10.121

10.  The seasonal variation of blood pressure in patients with essential hypertension.

Authors:  T Hata; T Ogihara; A Maruyama; H Mikami; M Nakamaru; T Naka; Y Kumahara; C A Nugent
Journal:  Clin Exp Hypertens A       Date:  1982
View more
  26 in total

1.  Interleukin 6 knockout prevents angiotensin II hypertension: role of renal vasoconstriction and janus kinase 2/signal transducer and activator of transcription 3 activation.

Authors:  Michael W Brands; Amy K L Banes-Berceli; Edward W Inscho; Hind Al-Azawi; Ashlyn J Allen; Hicham Labazi
Journal:  Hypertension       Date:  2010-10-04       Impact factor: 10.190

2.  Interleukin 6 underlies angiotensin II-induced hypertension and chronic renal damage.

Authors:  Weiru Zhang; Wei Wang; Hong Yu; Yujin Zhang; Yingbo Dai; Chen Ning; Lijian Tao; Hong Sun; Rodney E Kellems; Michael R Blackburn; Yang Xia
Journal:  Hypertension       Date:  2011-11-07       Impact factor: 10.190

3.  Interleukin-6 inhibition attenuates hypertension and associated renal damage in Dahl salt-sensitive rats.

Authors:  Shireen Hashmat; Nathan Rudemiller; Hayley Lund; Justine M Abais-Battad; Scott Van Why; David L Mattson
Journal:  Am J Physiol Renal Physiol       Date:  2016-06-08

Review 4.  Renal inflammation, autoimmunity and salt-sensitive hypertension.

Authors:  Bernardo Rodríguez-Iturbe; Martha Franco; Edilia Tapia; Yasmir Quiroz; Richard J Johnson
Journal:  Clin Exp Pharmacol Physiol       Date:  2012-01       Impact factor: 2.557

5.  Antiaging Gene Klotho Regulates Adrenal CYP11B2 Expression and Aldosterone Synthesis.

Authors:  Xiaoli Zhou; Kai Chen; Yongjun Wang; Mariano Schuman; Han Lei; Zhongjie Sun
Journal:  J Am Soc Nephrol       Date:  2015-10-15       Impact factor: 10.121

Review 6.  The immunological basis of hypertension.

Authors:  Bernardo Rodríguez-Iturbe; Héctor Pons; Yasmir Quiroz; Richard J Johnson
Journal:  Am J Hypertens       Date:  2014-08-23       Impact factor: 2.689

7.  The combined effects of silicon dioxide nanoparticles and cold air exposure on the metabolism and inflammatory responses in white adipocytes.

Authors:  Yongqiang Zhang; Xi Li; Yangsheng Lin; Li Zhang; Zhan Guo; Dandan Zhao; Danfeng Yang
Journal:  Toxicol Res (Camb)       Date:  2017-07-06       Impact factor: 3.524

Review 8.  Role of the Immune System in Hypertension.

Authors:  Bernardo Rodriguez-Iturbe; Hector Pons; Richard J Johnson
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

Review 9.  Vascular Smooth Muscle Remodeling in Conductive and Resistance Arteries in Hypertension.

Authors:  Isola A M Brown; Lukas Diederich; Miranda E Good; Leon J DeLalio; Sara A Murphy; Miriam M Cortese-Krott; Jennifer L Hall; Thu H Le; Brant E Isakson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-09       Impact factor: 8.311

10.  Inhibition of phosphodiesterase-1 attenuates cold-induced pulmonary hypertension.

Authors:  Patrick Crosswhite; Zhongjie Sun
Journal:  Hypertension       Date:  2013-01-14       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.